CXI Healthcare Technology Group Limited (KOSDAQ:900120)

KOSDAQ:900120 Income Statement

Financials in millions KRW. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	64,392	69,420	71,617	101,376	104,593	63,406
Other Revenue	-	-	-	0	-	-
Revenue	64,392	69,420	71,617	101,376	104,593	63,406
Revenue Growth (YoY)	-4.17%	-3.07%	-29.35%	-3.08%	64.96%	-50.97%
Cost of Revenue	39,665	39,544	43,405	73,018	82,777	74,839
Gross Profit	24,726	29,876	28,213	28,358	21,816	-11,434
Selling, General & Admin	7,279	5,326	10,682	12,638	12,037	39,864
Research & Development	584.02	4,939	9,750	9,317	3,818	10,858
Other Operating Expenses	23.03	136.77	144.34	152.96	404.64	184
Operating Expenses	7,823	11,223	21,077	22,067	17,287	50,516
Operating Income	16,903	18,653	7,136	6,292	4,529	-61,950
Interest Expense	-3.98	-5.06	-2.86	-53.79	-17.39	-6.82
Interest & Investment Income	243.37	257.51	230.33	141.06	324.04	1,826
Earnings From Equity Investments	133.34	285.34	235.78	-	-	-
Currency Exchange Gain (Loss)	-206.3	-128.15	62.53	-142.41	208.78	-50.77
Other Non Operating Income (Expenses)	-7.81	5.39	27.72	235.82	41.7	-18.5
EBT Excluding Unusual Items	17,062	19,068	7,689	6,472	5,086	-60,200
Gain (Loss) on Sale of Investments	6,574	6,574	-	-	-	-
Gain (Loss) on Sale of Assets	-33.48	3,697	-	-491.11	-	-12.23
Asset Writedown	-	-	-161.3	-	-	-40,435
Other Unusual Items	7.97	2.42	-	-	-	2,040
Pretax Income	23,611	29,342	7,528	5,981	5,086	-98,607
Earnings From Continuing Operations	23,611	29,342	7,528	5,981	5,086	-98,607
Minority Interest in Earnings	0.21	6.93	0.02	0.25	11.71	169.83
Net Income	23,611	29,349	7,528	5,981	5,098	-98,437
Net Income to Common	23,611	29,349	7,528	5,981	5,098	-98,437
Net Income Growth	12.37%	289.87%	25.86%	17.33%	-	-
Shares Outstanding (Basic)	294	252	121	121	111	110
Shares Outstanding (Diluted)	294	252	123	123	111	110
Shares Change (YoY)	61.01%	105.73%	-	10.22%	0.77%	-
EPS (Basic)	80.36	116.34	62.34	49.53	45.82	-891.61
EPS (Diluted)	79.31	116.34	61.39	48.00	45.82	-892.00
EPS Growth	-31.49%	89.51%	27.89%	4.75%	-	-
Free Cash Flow	45,648	43,666	31,597	35,979	-196,165	-110,022
Free Cash Flow Per Share	155.37	173.09	257.68	293.40	-1763.18	-996.54
Gross Margin	38.40%	43.04%	39.39%	27.97%	20.86%	-18.03%
Operating Margin	26.25%	26.87%	9.96%	6.21%	4.33%	-97.70%
Profit Margin	36.67%	42.28%	10.51%	5.90%	4.87%	-155.25%
Free Cash Flow Margin	70.89%	62.90%	44.12%	35.49%	-187.55%	-173.52%
EBITDA	41,395	43,296	31,116	32,004	23,198	-47,994
EBITDA Margin	64.29%	62.37%	43.45%	31.57%	22.18%	-75.69%
D&A For EBITDA	24,492	24,642	23,980	25,713	18,669	13,956
EBIT	16,903	18,653	7,136	6,292	4,529	-61,950
EBIT Margin	26.25%	26.87%	9.96%	6.21%	4.33%	-97.70%
Advertising Expenses	-	675.56	1,284	1,195	1,542	30,028

Source: S&P Global Market Intelligence. Standard template. Financial Sources.